Southern Star Research Pty Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Gordon Australia (2010)

Organization Overview

First Clinical Trial
2017
NCT03179423
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Southern Star Research | Southern Star Research Pty Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

gnbac1 (1 trial)

Drugs in Phase 1 Trials (5)

artemether (1 trial)

bsi-045b (1 trial)

lumefantrine (Coartem) (1 trial)

mmv 533 (1 trial)

ruxolitinib (jakafi) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Malaria (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 6